Post Marketing Information DHCPL 18/03/2024 Zyrtec-D - Risks of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome associated with the use of pseudoephedrine
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Tablet, Film Coated, Cetirizine Dihydrochloride 5 mg + Pseudoephedrine Hydrochloride 120 mg National University Hospital Woodlands Health Campus